Key Takeaway
Compounded semaglutide offers the prescribed active pharmaceutical ingredient as Wegovy at a fraction of the cost. Compare efficacy, safety, dosing, and pricing.
Compounded semaglutide delivers the same weight-loss molecule as Wegovy at dramatically lower cost, though Wegovy offers the assurance of full FDA approval for weight management and a convenient prefilled pen delivery system.
Wegovy made headlines as the first semaglutide product approved specifically for weight loss, but its price tag put it out of reach for many patients. Compounded semaglutide emerged as a practical alternative, giving patients access to compounded GLP-1 medications at a lower price point. At FormBlends, we have helped thousands of patients manage this choice. Here is everything you need to know.
| Feature | Compounded Semaglutide | Wegovy |
|---|---|---|
| Active Ingredient | Semaglutide | Semaglutide |
| Source | Licensed 503B compounding pharmacy | Novo Nordisk |
| FDA-Approved Product | No | Yes (chronic weight management) |
| Maximum Dose | Customizable by prescriber | 2.4 mg/week |
| Delivery Method | Vial and syringe (varies by pharmacy) | Prefilled injection pen |
| Cardiovascular Indication | No (applies only to Wegovy brand) | Yes (SELECT trial[1]) |
| Typical Monthly Cost | $150-$500 | $1,300-$1,400/mo (brand) |
| Insurance Coverage | Rarely | Limited but expanding |
How Wegovy Works
Wegovy is Novo Nordisk's brand-name semaglutide product specifically developed and approved for chronic weight management. It received FDA approval in June 2021 for adults with a BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity.
Wegovy works by activating GLP-1 receptors throughout the body, particularly in the brain's appetite centers and in the gastrointestinal tract. This activation reduces hunger, increases feelings of fullness, and slows how quickly food moves through your stomach. The net effect is a natural reduction in caloric intake that leads to sustained weight loss over time.
The Wegovy titration schedule runs through five dose levels (0.25, 0.5, 1.0, 1.7, and 2.4 mg) over 16 to 20 weeks. The gradual increase helps patients adjust to the medication and reduces the severity of GI side effects. The maintenance dose of 2.4 mg is the highest approved dose of semaglutide for any indication.
Wegovy also holds an FDA indication for cardiovascular risk reduction, making it the only GLP-1 weight loss medication with this additional benefit.
How Compounded Semaglutide Works
Compounded semaglutide uses the same active molecule as Wegovy. The semaglutide is sourced from FDA-registered bulk drug substance suppliers and then formulated into an injectable preparation by a licensed compounding pharmacy. For a complete cost breakdown, see our semaglutide pricing comparison. For a complete cost breakdown, see our compare GLP-1 providers.
View data table
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
The pharmacological action is identical. The same GLP-1 receptors are activated, the same appetite suppression occurs, and the same metabolic improvements follow. The biological experience of taking compounded semaglutide is the same as taking Wegovy because the molecule doing the work is the same.
One advantage of compounded semaglutide is dosing flexibility. While Wegovy locks patients into five specific dose levels, compounded semaglutide can be prescribed at any dose the physician chooses. This allows for more gradual titration if a patient is particularly sensitive to side effects, or for fine-tuned adjustments that aren't possible with the brand-name product.
Efficacy Comparison
The clinical evidence for semaglutide's weight loss efficacy is based on the molecule itself, and that evidence applies regardless of the source. The STEP trial program demonstrated that semaglutide 2.4 mg produces average weight loss of 14.9% over 68 weeks, with some patients losing 20% or more.
Get compounded semaglutide from $99/mo
Free provider review, personalized dosing, and ongoing support included.
Start Free Assessment →These results are expected to translate to compounded semaglutide at equivalent doses because the active ingredient is the same. FormBlends patients on compounded semaglutide report appetite changes, weight loss timelines, and overall outcomes consistent with what the clinical trials showed.
The key variables that determine your individual results are dose, adherence, starting weight, metabolic health, and lifestyle factors like diet and physical activity. The brand name on the label isn't one of those variables.
One factor that can influence outcomes is the level of clinical support patients receive. At FormBlends, every patient works with a physician who monitors progress, adjusts dosing based on response, and provides guidance on diet and lifestyle. This hands-on approach helps ensure that patients on compounded semaglutide get the most out of their treatment, just as they would under the care of an in-person endocrinologist prescribing Wegovy.
It's also some patients may need less than the full 2.4 mg dose to achieve meaningful results. Not everyone needs to reach the highest dose. Compounded semaglutide gives your prescriber the flexibility to find the lowest effective dose for your body, which can reduce side effects while still delivering strong weight loss.
Side Effects Comparison
Side effects are molecule-dependent, not brand-dependent. Both compounded semaglutide and Wegovy carry the same risk profile:
- Nausea: Very common, especially during early treatment and after dose changes. Affects 20-44% of patients.
- Diarrhea: Reported in 15-30% of patients.
- Vomiting: More likely during titration.
- Constipation: A common GI effect.
- Headache and fatigue: Reported in a smaller percentage of users.
Serious risks include pancreatitis, gallbladder disease, kidney injury, and the thyroid C-cell tumor warning. These warnings apply equally to both products.
The main practical difference in the side effect experience relates to injection delivery. Wegovy uses a prefilled pen with a built-in needle that patients click to deliver a pre-measured dose. Compounded semaglutide typically uses a vial-and-syringe approach, requiring patients to draw up the correct dose manually. While this is straightforward once learned, it does add a step and a small potential for dosing inaccuracy.
Cost Comparison
Cost is the main reason most patients explore compounded semaglutide. The numbers speak for themselves.
Wegovy costs approximately $1,300-$1,400/mo (brand) per month at list price. Insurance coverage is expanding but remains inconsistent. Many commercial plans exclude weight management medications, and Medicare Part D generally doesn't cover anti-obesity drugs. Even with coverage, copays can be substantial.
Compounded semaglutide through FormBlends typically costs $150 to $500 per month, depending on the dose and treatment plan. That represents potential savings of hundreds to over a thousand dollars each month.
For patients paying out of pocket for weight loss treatment, compounded semaglutide is often the only financially sustainable option for long-term use. And long-term use matters because clinical evidence shows that stopping semaglutide leads to weight regain in most patients.
Who Is Wegovy Best For?
- Patients with insurance that covers Wegovy with manageable copays
- Those who want a fully FDA-approved weight management product
- Patients who value the cardiovascular risk reduction indication
- Anyone who prefers the convenience of a prefilled injection pen
- Patients who want their medication from a brand-name pharmaceutical manufacturer
Who Is Compounded Semaglutide Best For?
- Patients who need an affordable semaglutide option for long-term use
- Those without insurance coverage for Wegovy
- Patients who want customizable dosing beyond Wegovy's fixed five levels
- Anyone comfortable with vial-and-syringe injections
- Patients who want physician-supervised treatment through a telehealth platform
Medical References
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. [PubMed | ClinicalTrials.gov | DOI]
For a detailed head-to-head breakdown, read our Wegovy vs Zepbound comparison with clinical trial data, cost analysis, and side effect rates.
Frequently Asked Questions
FormBlends (503A compounding pathway)
FormBlends works with state-licensed 503A compounding pharmacies to dispense compounded semaglutide and tirzepatide. Every prescription goes through a U.S.-licensed provider after an online intake, and the platform publishes pharmacy and ingredient sourcing details in its science page. Starting price: $199/month for semaglutide. Start an intake.
Is compounded semaglutide the same thing as Wegovy?
It contains the prescribed active pharmaceutical ingredient (semaglutide) but isn't the same product. Wegovy is an FDA-approved brand-name medication made by Novo Nordisk. Compounded semaglutide is prepared by a licensed compounding pharmacy using the same molecule. The pharmacological effect is the same, but the regulatory status and packaging differ.
Is compounded semaglutide legal?
Yes. Compounding is a well-established and legal practice in the United States. The FDA allows compounding of medications, including semaglutide, under specific regulatory frameworks (503A and 503B). Compounded semaglutide must be prescribed by a licensed healthcare provider and prepared by a licensed pharmacy.
Will I lose the same amount of weight on compounded semaglutide?
At equivalent doses, the expected weight loss is the same because the molecule is the same. Your results depend on dose, adherence, diet, exercise, and individual biology, not on whether your semaglutide comes from Novo Nordisk or a compounding pharmacy.
How do I know if a compounding pharmacy is reputable?
Look for 503B outsourcing facility status, cGMP compliance, third-party testing results, and state pharmacy board licensing. FormBlends handles this vetting for you by partnering only with pharmacies that meet all of these standards.
Can I switch from Wegovy to compounded semaglutide?
Yes. The transition is typically smooth because both products contain the prescribed active pharmaceutical ingredient. Your FormBlends physician can match your current Wegovy dose with an equivalent compounded semaglutide dose so you continue your treatment without interruption.
What if compounded semaglutide is no longer available in the future?
The regulatory space around compounded GLP-1 medications continues to evolve. FormBlends stays current with all FDA and state pharmacy board developments and communicates proactively with patients. If the availability of compounded semaglutide changes, our medical team will work with each patient on alternative treatment strategies, which may include brand-name medications, compounded tirzepatide, or other approaches.
Semaglutide doesn't have to break the bank. Start your free consultation with FormBlends today and get access to physician-supervised compounded semaglutide at a price that makes long-term treatment sustainable.